Literature DB >> 22346375

Scedosporium prolificans fungemia.

S Elsayed1, R Lannigan, I Chin-Yee.   

Abstract

Fungemia due to Scedosporium prolificans is described in a young woman with a relapse of acute lymphoblastic leukemia. Several days after starting reinduction chemotherapy, the patient presented with fever, neutropenia and blood cultures showing fungi on Gram stain. The patient died despite therapy with antifungal agents, including fluconazole and amphotericin B. Fungi grew from blood cultures, and was subsequently identified as Scedosporium prolificans.

Entities:  

Keywords:  Acute lymphoblastic leukemia; Fungemia; Leukemia; Scedosporium prolificans

Year:  1999        PMID: 22346375      PMCID: PMC3250745          DOI: 10.1155/1999/635193

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  6 in total

1.  Scedosporium inflatum, an emerging pathogen.

Authors:  I F Salkin; M R McGinnis; M J Dykstra; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

Review 2.  Scedosporium inflatum infection in immunocompromised haematological patients.

Authors:  M Tapia; C Richard; J Baro; R Salesa; J Figols; F Zurbano; A Zubizarreta
Journal:  Br J Haematol       Date:  1994-05       Impact factor: 6.998

3.  Petriellidosis (pseudallescheriasis) in southwestern Ontario, Canada.

Authors:  A Bakerspigel; D Schaus
Journal:  Sabouraudia       Date:  1984

4.  Potted plants in hospitals as reservoirs of pathogenic fungi.

Authors:  R C Summerbell; S Krajden; J Kane
Journal:  Mycopathologia       Date:  1989-04       Impact factor: 2.574

5.  Scedosporium inflatum: clinical spectrum of a newly recognized pathogen.

Authors:  C M Wilson; E J O'Rourke; M R McGinnis; I F Salkin
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

6.  Clinical features of human infection with Scedosporium inflatum.

Authors:  G M Wood; J G McCormack; D B Muir; D H Ellis; M F Ridley; R Pritchard; M Harrison
Journal:  Clin Infect Dis       Date:  1992-05       Impact factor: 9.079

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.